Discover Neoantigens that are Disease Relevant
Discover highly immunogenic neoantigens for potential application in personalized cancer therapeutics through a mutagenome wide CD8+ T cell analysis using peripheral blood mononuclear cells, dissociated tumor or lymphoid tissue with ImmunoScape’s sensitive and reliable platform.
Our powerful Immune Profiling and Bioinformatics Tools provide Key Benefits:
- Identify phenotypic differences between neoantigen-specific CD8+ T cells in responder vs non-responder patients
- Identify immunogenic neoantigens that can be leveraged for immunomonitoring during patient treatment
- Discover patient- or disease-specific highly immunogenic treatment targets for vaccine development or cell therapy strategies
- Gain a deeper understanding of cancers and their associated patient’s immune status
Fehlings et al., J Immunotherapy of Cancer 2019